Close menu




June 29th, 2026 | 06:30 CEST

Physical AI Outshines Everything Else: First Hydrogen, XPeng, and Schaeffler Are Benefiting from the "Next Big Thing"

  • Hydrogen
  • cleantech
  • Robotics
  • AI
  • semiconductor
  • Software
Photo credits: Pixabay

Experts agree that humanoid robots are among the largest future technology markets of the coming decades. Physical AI refers to AI systems that not only process information but also enable machines to perceive their environment, make decisions, and act autonomously in the real world. This forms the technological foundation for applications such as humanoid robots, autonomous vehicles, drones, and a new generation of intelligent production systems. Physical AI is thus an ecosystem that connects semiconductors, software, sensor technology, robotics, and automation. But it is not just manufacturers of humanoid robots that stand to benefit—numerous suppliers along the value chain will as well. We look at what this means specifically for First Hydrogen, XPeng and Schaeffler.

time to read: 4 minutes | Author: Carsten Mainitz
ISIN: First Hydrogen Corp. | CA32057N1042 | TSXV: FHYD , XPeng Inc ADR | US98422D1054 , SCHAEFFLER AG | DE000SHA0100

Table of contents:


    First Hydrogen: A Strategic Shift with Significant Implications

    The company's roots lie in the hydrogen sector. Here, the Canadian firm is pursuing an integrated approach, focusing not only on the production of light commercial vehicles powered by hydrogen fuel cells but also on building infrastructure for the production and supply of green hydrogen.

    In the hydrogen business, First Hydrogen can look back on a series of successes. Its activities in collaboration with research partners in the field of small modular reactors (SMRs) are also promising. These modular reactors are predicted to have a bright future in light of the rapid rise in electricity consumption driven, among other things, by AI data centers.

    The company recently announced a pioneering strategic shift and is consistently implementing its transformation from a hydrogen company to a technology company with multiple future growth areas. Specifically, the focus is on the billion-dollar market for humanoid robotics.

    The focus is on the planned acquisition of a 60% majority stake in Exodus Actuation Solutions. The company develops high-precision actuators, electric motors, drive systems, and motion controls, which are essential components of humanoid robots, and holds more than 30 granted and pending patents.
    The transaction involves the issuance of 2 million shares as well as an investment of USD 2 million in several stages. This allows the Canadian company to gain access to this massive market at a very moderate valuation. First Hydrogen also founded the subsidiary "First Humaid" with the goal of focusing on intellectual property, robotics, and AI applications.

    Humanoid robots consist of dozens of joints. Each of these joints requires an actuator. Actuators combine an electric motor, gearbox, sensors, and control electronics into a compact system. Only through actuators can a robot move fluidly. Actuators can be compared to the muscles of the human body.

    The US investment bank Morgan Stanley estimates that the market for humanoid robots will reach USD 5 trillion by 2050 and that around 1 billion humanoid robots will be in use by then. The stock has not yet reacted to these enormous growth opportunities and is trading at CAD 0.45, giving the company a market capitalization of approximately CAD 41 million.

    XPeng: China's Answer to Tesla

    Tesla is one of the key players in the field of Physical AI and plans to bring its humanoid robot "Optimus" to market. The company is leveraging its existing expertise in autonomous driving and AI software to combine robotics and vehicle technology into a single platform.

    The counterweight to the US company is XPeng from China. XPeng not only develops electric vehicles but is also investing heavily in autonomous driving, its own AI chips, and humanoid robots. With "IRON," the Chinese company is developing a humanoid assistant initially intended for use in its own production facilities.

    Particularly exciting and promising is the development of a technological platform that combines sensors, cameras, computing power, and AI models, designed for autonomous driving. This platform can also be used for humanoid robots, creating significant synergies.

    The stock is currently trading at around USD 12, marking a decline of about 40% since the beginning of the year. Analysts predict that the company will post a loss for the last time in the current fiscal year, followed by dynamic profit growth. Experts estimate an average upside potential of over 80% for the shares.

    Schaeffler: A Supplier with Many Partnerships

    The German industrial group has decades of experience in precision mechanics and electric drive systems. The company is now specifically applying this expertise to the robotics market. Using a modular actuator platform, Schaeffler is developing intelligent joints for humanoid robots. These combine an electric motor, gearbox, sensors, and control electronics into a compact system.

    In addition, the group is collaborating with over 40 robotics companies and plans to supply them with the components it produces. As a supplier, the company thus stands to benefit from the expected broad market growth, regardless of who comes out on top. Furthermore, Schaeffler intends to use the robots in its own production later on. The company has projected an order backlog in the triple-digit million-euro range in the humanoid robot segment by 2030.

    Its primary focus as an automotive supplier, along with the associated challenging industry conditions, has recently put pressure on the stock. The share is currently trading at just under EUR 8 per share, valuing the company at around EUR 7.5 billion. Analysts forecast losses for 2026. The outlook is expected to improve in 2027, with a 2027 P/E ratio of 12. Experts estimate the stock's upside potential at around 20%.


    Humanoid robots are creating a massive growth market. XPeng is positioning itself in this space with its own model and technology platform. Following the recent price declines, analysts see significant upside potential. Schaeffler has established over 40 partnerships in the field of robotics, thereby creating a strong foundation early on to benefit from the market trend. With its strategic pivot, the planned acquisition of a company, and the establishment of a subsidiary, First Hydrogen also has opportunities to benefit from strong market growth. Given the potential in robotics, the current market capitalization still has room to grow.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Carsten Mainitz

    The native Rhineland-Palatinate has been a passionate market participant for more than 25 years. After studying business administration in Mannheim, he worked as a journalist, in equity sales and many years in equity research.

    About the author



    Related comments:

    Commented by André Will-Laudien on June 29th, 2026 | 07:30 CEST

    AI and M&A Frenzy in the Life Sciences Sector: Bayer, Vidac Pharma, Novo Nordisk, Evotec, and Eli Lilly

    • Biotechnology
    • Pharma
    • Biotech
    • AI
    • Investments

    Yes, you read that correctly. Pharmaceutical companies are actively embracing artificial intelligence (AI) and, thanks to lower costs, better validation, and faster study setups, could emerge as winners of the new AI wave in the medium term. Many stocks in the life sciences sector had been overlooked by the market, but investors are now taking notice again. Eli Lilly is betting on AI and expanding its portfolio through targeted acquisitions, including the takeovers of sleep-wake specialist Centessa Pharmaceuticals and blood cancer specialist Ajax. At Evotec and Vidac Pharma, much of the focus is on cancer, while Novo Nordisk faces stiff competition from Eli Lilly's weight-loss drugs. Then came the welcome news regarding Bayer. The Supreme Court ruled that approximately 181,000 individual lawsuits alleging a lack of warning labels on packaging are no longer legally viable, as the US Environmental Protection Agency (EPA) has classified the herbicide glyphosate as safe. Lots of good news, and plenty of opportunities for active investors - we provide a few insights.

    Read

    Commented by Tarik Dede on June 29th, 2026 | 07:20 CEST

    Boom, Thanks to the AI Loop: Broadcom, HPQ Silicon, and GitLab

    • Silicon
    • Hydrogen
    • Batteries
    • AI
    • Defense

    Whether it is the AI revolution, quantum computing, or electric vehicles, the tech sector is booming worldwide—from the Nasdaq to the KOSPI. Keeping pace with this growth requires a massive expansion of infrastructure. Data centers and semiconductor manufacturing capacity are being built out at an unprecedented rate, while memory and chip equipment suppliers are ramping up production. Artificial intelligence is driving this process itself. This phenomenon is known as "recursive self-improvement." AI is currently becoming faster and more capable through three reinforcing mechanisms: it writes better code by building on previous generations of AI, it optimizes hardware—such as the design of next-generation AI chips from Nvidia or Broadcom—and it discovers more efficient circuit designs than human engineers could achieve on their own. The result is a powerful feedback loop that is also delivering major benefits to other industries. Today, we take a closer look at three technology companies that stand to benefit from this trend: Broadcom, HPQ Silicon, and GitLab. Without Broadcom, none of this would be possible.

    Read

    Commented by Nico Popp on June 29th, 2026 | 07:00 CEST

    Hydrogen Is Gaining Ground in Emerging Markets - How the Transition Can Succeed: Trimble, Nel, dynaCERT

    • Hydrogen
    • cleantech
    • greenhydrogen
    • transition
    • Fuelcells

    While the long-term goal of completely emission-free mobility remains, opinions on the path to achieving it vary widely. Especially in light of the sluggish economy and major challenges, more and more economies are turning to pragmatic solutions. Many technological and infrastructural hurdles can be circumvented in this way. Since the conversion of large commercial vehicle fleets to battery or fuel cell systems is likely to take decades for well-known reasons, transition technologies are gaining importance. We shed light on the market and introduce three promising players.

    Read